166 related articles for article (PubMed ID: 19654036)
1. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
[TBL] [Abstract][Full Text] [Related]
2. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
3. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.
Douay L; Giarratana MC; Labopin M; Bardinet D; Bouchet S; Gorin NC
Bone Marrow Transplant; 1995 May; 15(5):769-75. PubMed ID: 7670404
[TBL] [Abstract][Full Text] [Related]
4. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
[TBL] [Abstract][Full Text] [Related]
5. Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
McQuaker IG; Haynes AP; Iqbal A; Russell NH
Bone Marrow Transplant; 1996 Jul; 18(1):263-4. PubMed ID: 8832036
[No Abstract] [Full Text] [Related]
6. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
[TBL] [Abstract][Full Text] [Related]
7. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
Domenech J; Desbois I; Linassier C; Gihana E; Chenault S; Brémond JL; Colombat P; Lamagnère JP; Binet C
Bone Marrow Transplant; 1993 Jun; 11(6):425-31. PubMed ID: 8334422
[TBL] [Abstract][Full Text] [Related]
9. Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment.
Tarella C; Ferrero D; Siena S; Gallo E; Bondesan P; Bregni M; Pileri A; Gianni AM
Haematologica; 1990; 75 Suppl 1():11-4. PubMed ID: 2351338
[TBL] [Abstract][Full Text] [Related]
10. Determining factors for the outcome of peripheral blood progenitor cells harvests.
Keung YK; Cobos E; Dunn D; Park M; Dixon S; Wu K; Park CH
J Clin Apher; 1996; 11(1):23-6. PubMed ID: 8722718
[TBL] [Abstract][Full Text] [Related]
11. [Biological screening of immuno-mediated marrow insufficiency by means of the CFU-GM assay].
Ghizzi A; Carlo Stella C; Bonfichi M; Gorini M; Pedrazzoli P
Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2179-85. PubMed ID: 6525277
[TBL] [Abstract][Full Text] [Related]
12. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
Genevay MC; Mormont C; Thomas F; Berthier R
Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
[TBL] [Abstract][Full Text] [Related]
13. Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
Tang-naitrisorana Y; Issaragrisil S; Visuthisakchai S; Suvatte V; Piankijakum A
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():291-5. PubMed ID: 8629127
[TBL] [Abstract][Full Text] [Related]
14. [Effect of chemotherapy on hematopoietic stem cells in peripheral blood].
Nieto MJ; Cañizo C; Corral M; Almeida J; San Miguel J
Sangre (Barc); 1996 Feb; 41(1):29-35. PubMed ID: 8779031
[TBL] [Abstract][Full Text] [Related]
15. Normal blast colony formation: an in vitro tool for monitoring human bone marrow 'purging'.
Degliantoni G; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1986 Dec; 1(2):209-13. PubMed ID: 3332133
[TBL] [Abstract][Full Text] [Related]
16. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
Giarratana MC; Gorin NC; Douay L
Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
[TBL] [Abstract][Full Text] [Related]
17. Variations in committed stem cells (CFU-GM and CFU-TL) in the peripheral blood of cancer patients treated by sequential combination chemotherapy for breast cancer.
Rusé-Riol F; Legros M; Bernard D; Chassagne J; Clavel H; Ferriere JP; Chollet P; Plagne R
Cancer Res; 1984 May; 44(5):2219-24. PubMed ID: 6713410
[TBL] [Abstract][Full Text] [Related]
18. [A simple method for detecting immature precursors after in vitro bone marrow treatment with ASTA-Z 7654].
Lamana M; Fernández-Rañada JM
Sangre (Barc); 1991 Dec; 36(6):501-3. PubMed ID: 1812583
[TBL] [Abstract][Full Text] [Related]
19. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
Rowley SD; Piantadosi S; Santos GW
Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
[TBL] [Abstract][Full Text] [Related]
20. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Domenech J; Linassier C; Gihana E; Dayan A; Truglio D; Bout M; Petitdidier C; Delain M; Petit A; Brémond JL
Blood; 1995 Jun; 85(11):3320-7. PubMed ID: 7756665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
